1. 06 Jul 2021  |  North America  |  Market Research

    Global Decentralized Clinical Trial (DCT) Growth Opportunities

    Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum

    Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (CR...

    $2,450.00

    Special Price $1,837.50 save 25 %

  2. 01 Jul 2021  |  North America  |  Market Research

    Global Computed Tomography Growth Opportunities

    Increased Demand and Purchase Parameters on Multivariate Trends Propel Transformational Growth

    An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%–4%. CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management. The dynamic CT industry involves many participants introducing technological innovations frequently to ma...

    $4,950.00

    Special Price $3,712.50 save 25 %

  3. 30 Jun 2021  |  North America  |  Market Research

    US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities

    Telegenetic Counseling to Revolutionize Access to Patient Care

    In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

    $2,450.00

    Special Price $1,837.50 save 25 %

  4. 29 Jun 2021  |  North America  |  Frost Radar

    Frost Radar™: Digital Operating Rooms, 2020

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. 28 Jun 2021  |  North America  |  Market Outlook

    Global Medical Imaging & Informatics Outlook, 2021

    AI, Long-term Partnerships, and Cloud to Influence Growth Strategies

    The global medical imaging and informatics market is experiencing dynamic changes with the emergence of advanced technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, which is forcing industry participants to innovate to maintain their competitive edge. Technologies such as artificial intell...

    $4,950.00

    Special Price $3,712.50 save 25 %

  6. 23 Jun 2021  |  Global  |  Frost Radar

    Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

    A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

    Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 23 Jun 2021  |  Global  |  Technology Research

    Global RNA Therapeutics:Technology Growth Opportunities

    Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics

    RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  8. 17 Jun 2021  |  North America  |  Market Research

    Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

    Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

    This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

    $4,950.00

    Special Price $3,712.50 save 25 %

  9. 14 Jun 2021  |  North America  |  Market Research

    Growth Opportunities for MedTech in the Transformation of the US Healthcare Provider Ecosystem

    Transformational Growth in the Care Delivery Landscape is Changing Health Systems into Systems of Health

    Healthcare providers are on the verge of reinventing their role in the care delivery process due to various external factors, such as the following: • Unsustainable growth in healthcare spending driving continuous downward pressure and declining operating margins • The emergence of alternative payment models that focus on patient outcome and re...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 01 Jun 2021  |  North America  |  Frost Radar

    Frost Radar™: US Population Health Management Market, 2021

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...

    $4,950.00

    Special Price $3,712.50 save 25 %